Major players actively participating in Global Amyotrophic Lateral Sclerosis Market include Takeda Pharmaceutical Company Ltd., Mitsubishi Tanabe Pharma, Mylan Pharmaceuticals Inc., and Sanofi S.A.
Overview:Amyotrophic lateral sclerosis (ALS) is a neurological disease also known as Lou Gehrig's disease. The disease affects motor neurons, which control the action of voluntary muscles. Messages between the brain and muscle fibers are blocked. ALS may occur in a person because of a genetic inheritance, a gene mutation encoding the copper-zinc superoxide-dismutase enzyme associated with a chromosome 9 defect. This disease is more prevalent in men. All these abnormalities lead to the release of glutamate which damages the motor neurons that control the voluntary muscles. ALS has many symptoms such as spasticity, cramps, fasciculation, breathing problems and muscle weakness. The mortality rate has been studied to be higher in patients with ALS, mainly due to respiratory failure. ALS causes the inability to breathe, which is due to the lack of function of the diaphragm and chest muscles caused by muscle weakness. It is estimated that about 5,000 people in the United States die because of this disease each year.
Browse report brief and TOC @ https://www.researchcosmos.com/reports/amyotrophic-lateral-sclerosis-in-9-major-markets-forecast-report-2016-2026/2071405344
Drivers and Restraints:
The growing aging of the world's population would increase the growth of this market. In addition, the government is also concerned about the different treatment options for ALS. Recently, in 2008, the Collaborative ALS Drug Discovery Initiative (ALS) initiated and accelerated the development of new drugs and the effective treatment of ALS. This initiative increased the number of ALSs that were treating drugs in progress. Nevertheless, several factors, such as the high cost of treatment, ignorance of the disease and the availability of ineffective diagnostic methods, would hinder the growth of this market.
Geographic Segmentation:
On the basis of geography, Global Amyotrophic Lateral Sclerosis Market is segmented into regions such as North America, Latin America, Europe, Middle East and Africa and Asia Pacific. North America is expected to maintain a dominant position in the amyotrophic lateral sclerosis (ALS) market, with the region's main companies focusing on collaborations for product development. For example, in January 2018, Sangamo Therapeutics, Inc. and Pfizer Inc. collaborated to develop a potential gene therapy using zinc finger protein transcription factors (ZFP-TF) for the treatment of ALS. Companies based in emerging economies in Asia Pacific region is focusing on the development of new drugs for the treatment of ALS.
Key Players in Global Amyotrophic Lateral Sclerosis Market:
Major players actively participating in Global Amyotrophic Lateral Sclerosis Market include Takeda Pharmaceutical Company Ltd., Mitsubishi Tanabe Pharma, Mylan Pharmaceuticals Inc., and Sanofi S.A.
Request free sample @ https://www.researchcosmos.com/request/alzheimers-disease-in-12-major-markets-forecast-report-20/1780171530
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
LinkedIn - https://www.linkedin.com/company/market-research-cosmos
Twitter - https://twitter.com/researchcosmos
Google+ - https://plus.google.com/109756852849129986268
Facebook - https://www.facebook.com/researchcosmos/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major players actively participating in Global Amyotrophic Lateral Sclerosis Market include Takeda Pharmaceutical Company Ltd., Mitsubishi Tanabe Pharma, Mylan Pharmaceuticals Inc., and Sanofi S.A. here
News-ID: 1285017 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for ALS
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
Food Certification Market Future Growth Outlook | Intertek, BV, ALS
Latest survey on Food Certification Market is conducted to provide hidden gems performance analysis to better demonstrate competitive environment of Food Certification. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end use applications. The report bridges the historical data from 2015 to 2020 and forecasted till 2026*, the outbreak of latest scenario in Food…
ALS Treatment Market to Witness a Healthy CAGR of 19.21% by 2026 - ASURAGEN, INC …
Global ALS Treatment Market analysis report is also helpful in assessing the effectiveness of advertising programme and to know the causes of consumer resistance. The market report also contains the drivers and restraints for the ALS Treatment Market that are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, mergers and acquisitions by the several key players and brands that are driving the…
Amyotrophic Lateral Sclerosis (ALS) Treatment Market : Trends And Growth
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease (MND), is a neurodegenerative disease, affecting nerve cells in the brain and spinal cord that controls voluntary muscles. The disease is progressive in nature, meaning it gets worse over time.
According to a study published in Centers for Disease Control and Prevention, in 2016, around 14,713 people were diagnosed with ALS in the U.S. and prevalence rate…
Global Palladium Electrode Market 2018 - Metrohm, Murata, Kemet, ALS Co
The Global Palladium Electrode Market 2018 research report presents an in-depth research of the Global Palladium Electrode Sales Market alongside the Palladium Electrode market size and growth rate, classification of the Palladium Electrode industry based on products, and leading Palladium Electrode industry players as well. The Palladium Electrode industry report summarizes the global market insights that are key drivers for growth of the Palladium Electrode sales market over the forecast…